The company
LB Pharmaceuticals Inc
LBRX · Nasdaq
LBRX stood above a rising 150-day average in 23 of the last 23 weekly readings, every one of them. It is 12.0% above that average now. Biotechnology: 16% of its 561 stocks in an uptrend (−15 points in four weeks); Health Care: 26% (−10 points in four weeks).
Statistics
- Rotation
- Just started moving
- Weeks in an uptrend
- 23 in a row
- Industry in uptrend
- 16% -15 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $0
- Officials’ trades on record
- 0
- Institutions holding
- 112 (+37)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 23 of 23 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Deep Track Biotechnology Master Fund, Ltd.10% owner | bought | 286,205at $34.94 | 30 Jul 2026filed 3 Aug 2026 |
| Deep Track Biotechnology Master Fund, Ltd.10% owner | bought | 378,444at $21.17 | 6 Feb 2026filed 10 Feb 2026 |
| Deep Track Biotechnology Master Fund, Ltd.10% owner | bought | 93,925at $21.17 | 6 Feb 2026filed 10 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Deep Track Capital, LPunchanged · filed 14 Aug 2026 | 3,352,804$108.8M | 00.0% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 2,734,305$88.7M | +263,460+10.7% |
| RA CAPITAL MANAGEMENT, L.P.unchanged · filed 14 Aug 2026 | 2,208,604$71.7M | 00.0% |
| Trails Edge Capital Partners, LPadded · filed 14 Aug 2026 | 1,523,022$49.4M | +203,660+15.4% |
| Commodore Capital LPunchanged · filed 14 Aug 2026 | 1,500,000$48.7M | 00.0% |
| JPMORGAN CHASE & COnew · filed 12 Aug 2026 | 1,497,293$48.9M | +1,497,293 |
| TCG Crossover Management, LLCreduced · filed 14 Aug 2026 | 1,447,310$47.0M | -392,179−21.3% |
| Caligan Partners LPunchanged · filed 14 Aug 2026 | 1,438,070$46.7M | 00.0% |
| Spruce Street Capital LPunchanged · filed 13 Aug 2026 | 1,376,159$44.7M | 00.0% |
| Nantahala Capital Management, LLCunchanged · filed 14 Aug 2026 | 1,052,894$34.2M | 00.0% |
News
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.